Evidence Hub

PS-08-004 The effect of dapoxetine on semen quality in patients with premature ejaculation in China

Jing Peng, Z. Zhang, Yun Yuan, B. Gao

The Journal of Sexual Medicine, 2017

40 participants · 1 citation

Abstract

The efficacy and safety profiles of dapoxetine in men with premature ejaculation (PE) have been well established by global clinical trials. However, there was no reported study thus far on dapoxetine’s effect on semen quality. Young population with PE may have fertility desire; hence it is important to investigate whether dapoxetine treatment has any effect on semen quality. This study compared the semen quality before and after dapoxetine treatment in men without fertility desire, aiming to evaluate the effect of dapoxetine on semen quality. This prospective, open, observational study included 40 patients with PE who received dapoxetine treatment on-demand for 24 weeks. All patients had no fertility desire. Semen samples were collected before dapoxetine treatment and within 12 hours after the last dapoxetine taken respectively. Premature ejaculation diagnostic tool (PEDT), self-reported IELT and premature ejaculation profile (PEP), as well as the Clinical Global Impression of Change (CGIC) were used to assess treatment effectiveness of dapoxetine on PE. Sperm concentration, sperm forward mobility and pregnancy event were measured during treatment.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free